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Ethiopia is among the thirty-high tuberculosis (TB) burden 
countries with multidrug resistant tuberculosis (MDR-TB) and 
Tuberculosis/Human Immunodeficiency Virus (TB/HIV). Given 
the public health importance of the problem, it is apparent that 
probing the work done in this regard is essential to mitigate the 
problem and thus we reviewed research repositories and compile 
directories of researches in Ethiopia from Jan 1, 2001 to Dec 30, 
2017 in order to avail evidence-based information to stakeholders 
and beneficiaries intervening the problem in the country. The 
evidences generated in this bibliography are through different 
databases and websites using key terms. A range of different 
published and unpublished literatures (journal articles, 
conference presentations, reports/manual/book, and graduate 
theses or dissertations) on TB, MDR-TB, extensively drug 
resistant TB (XDR-TB), or TB/HIV are presented. We presented 
literatures by four themes (Biomedical and clinical researches, 
epidemiological researches, operational or implementation 
researches, and health systems researches). A total of 1571 
researches and reports were accessed through the above search 
engines and revealed 635 epidemiological researches followed by 
538 clinical or biomedical researches, 257 operational or 
implementation research, and 141 health systems research. 
Interestingly, up to 2008 clinical or biomedical researchers were 
the leading researches and from 2009 onwards, epidemiological 
researches held the largest constituency. In conclusion, TB or 
TB/HIV and MDR-TB literatures in Ethiopia have substantially 
increased over years. Referred journal publications took the 
leading source and epidemiologic studies were the commonest one. 
We suggest the need to focus on operational or implementation 
and health system researches to plummet the disease spreading, 
drug resistance and impact. We also recommend a regular update 
of the bibliography every 3 to 4 years with annotations.  
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This bibliography is a compendium of 
tuberculosis (TB) or TB/HIV and MDR-TB 
research done in Ethiopia from Jan 1, 2001 to 
Dec 30, 2017; a 17 years research corpus.  
 In this anthology, a range of different 
studies on TB, multi-drug resistant tuberculosis 
(MDR-TB), extensively drug resistant TB 
(XDR-TB), or TB/HIV are presented. The 
literature covered consists of published or 
unpublished research work on TB or TB/HIV 
with an exhaustive inclusion of all citations 
available through the 17 years period. It 
included TB or TB/HIV and MDR-TB records 
from journal articles, government or non-
governmental reports, global reports, graduate 
thesis or dissertation works, and other related 
references such a multi-center study that 
involved Ethiopia.  
 The aim of this bibliography is to 
establish TB or TB/HIV and MDR-TB 
research repositories and compile directories of 
research in order to facilitate access and 
availability of research data and information 
for use by policy makers, program planners, 
researchers, health care services communities, 
students, and beneficiaries. It will be beneficial 
also for the national TB prevention and control 





We systematically searched different 
databases and websites and took the utmost 
care not to miss articles through consistent 
effort to cover all available literature. While 
searching the literature in the database or on 
websites, key search terms and Boolean 
operators such as TB or Tuberculosis and 
Ethiopia, TB and HIV/AIDS and Ethiopia, 
MDR-TB and Ethiopia, XDR-TB and 
Ethiopia, TB and HIV and Ethiopia, TB and 
AIDS and Ethiopia were deployed.  
 The databases considered for 
scientific articles, short communications, 
editorial notes, and expert opinions were: 
MEDLINE/PubMed, Scopus, EMBASE, 
CINHAL, EBSCO, Web of Science, WHO 
Global Health Library databases, WHO Global 
Index Medicus, African Journal online 
(AJOL), ScienceDirect, EconLit, Global 
Health, POPLINE, and PsycINFO. Websites 
were also manually reviewed for non-indexed 
literature at the aforementioned databases. 
These websites were: International Union 
Against TB and Lung Diseases, Armauer 
Hansen Research Institute (AHRI), World 
Health Organization (WHO), Federal Ministry 
of Health (FMOH), Ethiopian Public Health 
Institute (EPHI), Ethiopian Public Health 
Association (EPHA), Ethiopian Journal of 
Health Sciences, Ethiopian Medical Journal, 
East African Journal of Health and Biomedical 
Sciences, Ethiopian Pharmacuitical Journal, 
and an in-house universities repository for 
graduate student thesis and dissertations works. 
Besides, the gray literature was searched 
through reference checking and journal or 
conference proceeding hand search including 
the FMOH Tuberculosis Advisory Committee 
(TRAC) abstract books. In addition, some level 
of attempt was made to contact experts in the 
area. We have also drawn from the 
“Bibliography on HIV/AIDS in Ethiopia and 
Ethiopians in the Diaspora” updates that are 
being published annually since 2002 on 
Ethiopian Journal of Health Development.  
Depending on the source of the literature, 
different methods were used to archive the 
citations irrespective of year of publication. 
We exported database articles mainly into 
Endnote library or Microsoft Office Comma 
Separated Value (CSV) file, and references 
either from the websites or gray literature were 
independently recorded in Microsoft Excel 
worksheet. All of the references from different 
sources were added up into a Microsoft Excel 
worksheet. While we critically examined the 
merged list of literature, references published 
before Jan 1, 2001 and after Dec 30, 2017 were 
removed and duplicated articles from different 
sources were also singled out.      
 The presentation of the citations is 
systematically categorized by four themes – 
namely: Biomedical and clinical researches, 
epidemiological researches, operational or 
implementation researches, and health systems 
researches. These thematic categories are 
adopted from the April 2016 National 
Tuberculosis Research plan by the National TB 
 








Research Advisory Committee (TRAC) of the 
Federal Ministry of Health (FMOH). 
Nevertheless, allocation of these references to 
the thematic categories listed above was 
challenging. This was because of the overlap 
between different studies that may make them 
eligible to be categorized into more than one 
theme. Nevertheless, we applied a single-entry 
method whereby one reference is assigned into 
either of the themes that may be overlapping. 
This would imply that readers need to exhaust 
all theme categories to access an article or 
publication they specifically look for. 
 
Summary of TB or TB/HIV and MDR-TB 
researches 
 
A total of 1571 references were found, among 
which 983, 359, 34, and 195 were journal 
articles, conference presentations, 
reports/manual/book, and graduate theses or 
dissertations, respectively. When one looks at 
the time trend of TB or TB/HIV and MDR-TB 
literature from 2001 to 2017, a substantial 
increase is observed from one year to the next 
although there are slight upward and downward 
changes during 2002 to 2006 (Figure 1).  
 
Figure 1: Total TB or TB/HIV and MDR-TB Literature in Ethiopia from 2001 to 2017 
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Figure 2: TB or TB/HIV and MDR-TB literatures in Ethiopia from 2001 to 2017 by type  
 
Likewise, journal articles were the main types 
of literature represented with substantial 
increase across the years (Figure 2). Overall, 
epidemiological researches (635) were the 
largest research types followed by clinical or 
biomedical researches (538) in the 17 years 
under review. However, up to 2008 clinical or 
biomedical researches were the leading in 
number and from 2009 onwards, the number 
of epidemiological researches held the largest 
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Literature List by Theme Categories  
 
The following are the lists of TB and HIV 
literature presented by theme category. Most of 
the literature list is the same as the source format 
to ease the retrieval of the documents when 
readers are in need. 
The listing order is alphabetical and a new 
numbering for the literature is used for each 
section. A total of 538, 635, 141, and 257 
literature lists were included in biomedical or 
clinical research, epidemiological research, 
health systems research, and operational or 
implementation research sections, respectively.    
 
Section 1: Biomedical or 
clinical research 
 
This category encompasses a wide array of 
research, extending from basic research – 
involving fundamental scientific principles that 
may apply to a preclinical understanding – to 
clinical research which involves studies of 
people who may be subjects in clinical trials and 
those that determine the safety and effectiveness 
(efficacy) of medications, devices, diagnostic 
products and treatment regimens intended for 
human use. A total of 538 references are 
included in this category. 
 
1. Abate D, Tedla Y, Meressa D, Ameni G. 
Isoniazid and rifampicin resistance 
mutations and their effect on second-line 
anti-tuberculosis treatment. Int J Tuberc 
Lung Dis 2014; 18(8):946-51. doi: 
10.5588/ijtld.13.0926. 
2. Abate E, Belayneh M, Gelaw A, et al. The 
impact of asymptomatic helminth co-
infection in patients with newly diagnosed 
tuberculosis in north-west Ethiopia. PLoS 
One 2012; 7(8): e42901. doi: 
10.1371/journal.pone.0042901. 
3. Abate E, Elias D, Getachew A, et al. 
Effects of albendazole on the clinical 
outcome and immunological responses in 
helminth co-infected tuberculosis patients: 
a double blind randomised clinical trial. Int 
J Parasitol 2015; 45(2-3):133-40. doi: 
10.1016/j.ijpara.2014.09.006. 
4. Abate G, Aseffa A, Selassie A, et al. Direct 
colorimetric assay for rapid detection of 
rifampin-resistant Mycobacterium 
tuberculosis. J Clin Microbiol 2004; 
42(2):871-3. 
5. Abate G, Koivula T, Hoffner SE. In vitro 
activity of thiacetazone on mycobacterial 
species belonging to the Mycobacterium 
tuberculosis complex. Int J Tuberc Lung 
Dis 2002; 6(10):933-5. 
6. Abay SM, Deribe K, Reda AA, et al. The 
Effect of Early Initiation of Antiretroviral 
Therapy in TB/HIV-Coinfected Patients: A 
Systematic Review and Meta-Analysis. J 
Int Assoc Provid AIDS Care 2015; 
14(6):560-70. doi: 
10.1177/2325957415599210. 
7. Abaye G. Detection of Mycobacterium 
tuberculosis in stool of HIV sero-positive 
patients with pulmonary tuberculosis. [MSc 
Thesis]: Addis Ababa University, 2014. 
8. Abaye GE, Abebe T, Worku A, Tolessa D, 
Ameni G, Mihret A. Detection of 
Mycobacterium tuberculosis from the stool 
of HIV sero-positive individuals suspected 
of pulmonary tuberculosis. PLoS One 2017; 
12(5):e0177529. doi: 
10.1371/journal.pone.0177529. 
9. Abdissa K, Tadesse M, Abdella K, Bekele 
A, Bezabih M, Abebe G. Added value of 
light emitting diode (LED)-based 
fluorescence microscopy for the diagnosis 
of tuberculous lymphadenitis.  Jimma 
University Annual Research Conference, 
February 5-6, 2015, Jimma University, 
Jimma, Ethiopia. 
10. Abdissa K, Tadesse M, Abdella K, Bekele 
A, Bezabih M, Abebe G. Diagnostic 
performance of fluorescent light-emitting 
diode microscopy for tuberculous 
lymphadenitis in a high-burden setting. 
Trop Med Int Health 2015; 20(11):1543-
1548. doi: 10.1111/tmi.12585. 
11. Abdissa K, Tadesse M, Bezabih M, et al. 
Bacteriological methods as add on tests to 
fine-needle aspiration cytology in diagnosis 
of tuberculous lymphadenitis: can they 
reduce the diagnostic dilemma? BMC 
Infect Dis 2014 Dec; 14:720. doi: 
10.1186/s12879-014-0720-z. 
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12. Abdurahman Said.  A comparative study of 
drug resistance in smear positive new and 
re-treatment cases of tuberculosis in the 
Somali region, Ethiopia. [Thesis]: Addis 
Ababa University, 2002. 
13. Abebe DD. Detecting Mycobacterium 
infection using whole blood interferon-γ 
Assay, QuantiFERON TB Gold in-Tube, 
among household contacts, community 
controls and tuberculosis patients in Addis 
Ababa. MSc Thesis: Aklilu Lemma 
Institute of Pathobiology, Addis Ababa 
University, 2013. 
14. Abebe F, Belay M, Legesse M, Mihret A, 
Franken KS. Association of ESAT-6/CFP-
10-induced IFN-Î³, TNF-Î and IL-10 with 
clinical tuberculosis: evidence from cohorts 
of pulmonary tuberculosis patients, 
household contacts and community controls 
in an endemic setting. Clin Exp Immunol 
2017; 189(2):241-249. doi: 
10.1111/cei.12972. 
15. Abebe F, Belay M, Legesse M. IFN-γ 
against the 38-kDa antigen of 
Mycobacterium tuberculosis discriminates 
pulmonary tuberculosis from infection and 
infection from exposure: evidence from a 
study of human population in a high 
endemic setting. APMIS 2017. doi: 
10.1111/apm.12793. 
16. Abebe G, Atomsa A, Deribew A. Detection 
of Pulmonary Tuberculosis by Smear 
Microscopy: Quality Control. Fifth national 
tuberculosis research conference, Jimma 
University, October 22, 2009, Jimma, 
Ethiopia. 
17. Abebe G, Rigouts L, CdeJong B, et al. 
GeneXpert MTB/RIF assay for the 
Diagnosis of Tuberculous Lymphadenitis 
on Concentrated Fine Needle Aspirates in 
High Tuberculosis Burden Settings. 
Tuberculosis Co-Morbidities and 
Immunopathogenesis (B6). Part of the 
Keystone Symposia Global Health Series, 
supported by the Bill & Melinda Gates 
Foundation. February 28 -March 3, 2016; 
Keystone Resort, Keystone, Colorado, 
USA. 
18. Abebe G, Romano M, Korf H, Huygen K.  
Evaluation of the host immune response 
raised against different isolates of 
Mycobacterium tuberculosis complex. 
Presented on Ethiopian third national 
tuberculosis research workshop at Armauer 
Hansen Research Institute (AHRI), 
December 22, 2006, Addis Ababa, 
Ethiopia. 
19. Abebe G. Genetic diversity of 
mycobacterium tuberculosis complex 
isolates assessed by spoligotyping around 
Jimma, Southwest Ethiopia. Belgian 
Scientific Institute of Public Health. July 2, 
2014, Brussels, Belgium. 
20. Abebe M, Aseffa A,  Zewdie M and Holm-
Hansen C. Proof of concept: Co-stimulation 
of Whole Blood with Mitogen and Antigen 
Leads to Enhanced Antigen Specific 
Interferon Gamma Release in TB HIV 
Coinfected Patients.  Abstracts Presented 
on 12th National TB Research Annual 
Conference, March 21-24 2017, Addis 
Ababa, Ethiopia. 
21. Abebe M, Doherty TM, Wassie L, et al. 
VACSEL study group Expression of 
apoptosis-related genes in an Ethiopian 
cohort study correlates with tuberculosis 
clinical status. Eur J Immunol 2010; 
40(1):291-301. doi: 10.1002/eji.200939856. 
22. Abebe M, Kim L, Rook G, et al. 
Modulation of cell death by M. tuberculosis 
as a strategy for pathogen survival. Clin 
Dev Immunol 2011;2011:678570. doi: 
10.1155/2011/678570. 
23. Abebe W, Abebe B, Molla K, Alemayehu 
T. Tuberculous Dactylitis: An Uncommon 
Presentation of Skeletal Tuberculosis. 
Ethiop J Health Sci 2016; 26(3):301-3. 
24. Abera A, Endalafer N, Girma S, et al. 
Diagnostic performance of Light Emitting 
Diode (LED) Fluorescence based 
Microscope for the diagnosis of 
Tuberculous Lymphadenitis from Fine 
Needle Aspirate. Abstracts Presented on 
10th TB Research Annual Conference, 
March 21- 23, 2015, Adama, Ethiopia 
25. Abil OZ. Tuberculosis lymphadenitis and 
immunophenotypic characterization of 
peripheral T lymphocytes among 
individuals clinically suspected of 
tuberculosis lymphadenitis at Tikur 
Anbessa Specialized Hospital, Addis 
Ababa, Ethiopia. MSc Thesis: Department 
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of Medical Microbiology, Addis Ababa 
University, 2013. 
26. Abossie A, Yohanes T. Assessment of 
isoniazid preventive therapy in the 
reduction of tuberculosis among ART 
patients in Arba Minch Hospital, Ethiopia. 
Ther Clin Risk Manag 2017; 13:361-366. 
doi: 10.2147/TCRM.S127765. 
27. Abyot Meaza. Evaluation of The 
Diagnostic Performance of Genotype 
MTBdrplus Ver 2.0 Line Probe Assay for 
the detection of Multidrug Resistance TB 
(MDR-TB) in sputum samples referred to 
national TB reference laboratory, Ethiopian 
Public Health Institute. [Thesis]: Addis 
Ababa University, 2015. 
28. Adane AA, Alene KA, Koye DN, Zeleke 
BM. Non-adherence to anti-tuberculosis 
treatment and determinant factors among 
patients with tuberculosis in northwest 
Ethiopia. PLoS One 2013; 8(11): e78791. 
doi: 10.1371/journal.pone.0078791. 
29. Adane K. Molecular characterization of 
mycobacterium tuberculosis isolates from 
HIV seropositive and sero-negative 
pulmonary tuberculosis patients in Eastern 
Gojjam, northern Ethiopia. [MSc Thesis]: 
Addis Ababa University, 2011. 
30. Addis Y. Comparison of tuberculosis skin 
test (TST) and QUANTIFERON-TB Gold 
for latent tuberculosis. [MSc Thesis]: Addis 
Ababa University, 2012. 
31. Addise D, Bitew A, Yaregal Z, et al. Effect 
of 1.5% sodium hydroxide final 
concentration on recovery rate of 
Mycobacterial Species and decontamination 
of Bacterial and Fungal contaminants on 
sputum.  Abstracts Presented on 12th 
National TB Research Annual Conference, 
March 21-24 2017, Addis Ababa, Ethiopia. 
32. Adelman MW, Tsegaye M, Kempker R, et 
al. Enhanced active TB case finding among 
people living with HIV: Impact of a rapid 
molecular test (Xpert MTB/RIF). J Investig 
Med 2014; 62 (2):570. 
33. Adelman MW, Tsegaye M, Kempker RR, 
et al. Intensified tuberculosis case finding 
among HIV-infected persons using a WHO 
symptom screen and Xpert(Â®) MTB/RIF. 
Int J Tuberc Lung Dis 2015; 19(10):1197-
203. doi: 10.5588/ijtld.15.0230. 
34. Aderaye G, Bruchfeld J, Aseffa G, et al. 
Pneumocystis jiroveci pneumonia and other 
pulmonary infections in TB smear-negative 
HIV-positive patients with atypical chest X-
ray in Ethiopia. Scand J Infect Dis 2007; 
39(11-12):1045-53. 
35. Aderaye G, Bruchfeld J, Olsson M, 
Lindquist L. Occurrence of Pneumocystis 
carinii in HIV-positive patients with 
suspected pulmonary tuberculosis in 
Ethiopia. AIDS 2003; 17(3):435-40. 
36. Aderaye G, G/Egziabher H, Aseffa A, 
Worku A, Lindquist L. Comparison of acid-
fast stain and culture for Mycobacterium 
tuberculosis in pre- and post-bronchoscopy 
sputum and bronchoalveolar lavage in HIV-
infected patients with atypical chest X-ray 
in Ethiopia. Ann Thorac Med 2007; 
2(4):154-7. doi: 10.4103/1817-1737.36549. 
37. Adewo DS. Clinical presentation and 
treatment of TB among HIV positive TB 
patients on short course DOTS in Hawassa 
Referral Hospital: A retrospective cohort 
study [MPH thesis]: Addis Ababa 
University, 2010. 
38. Admassu E, Yassin MA, Berhanu S, et al. 
Xpert MTB/RIF Diagnostic Gain in Smear-
Negative Presumptive TB Cases, Children 
and Individuals with HIV in Southern 
Ethiopia. Abstracts Presented on 11th 
National TB Research Annual Conference, 
March 21- 24, 2016, Dire Dawa, Ethiopia. 
39. Agonafir M, Lemma E, Wolde-Meskel D, 
et al. Phenotypic and genotypic analysis of 
multidrug-resistant tuberculosis in Ethiopia. 
Int J Tuberc Lung Dis 2010; 14(10):1259-
65. 
40. Agonafir M, Yassin MA, Datiko DG, 
Yassin MA, Theobald S, Cuevas LE. Use 
of Xpert MTB/RIF for diagnosis of TB and 
drug resistance in South, Ethiopia: 
communitybased intervention. Abstracts 
Presented on 12th National TB Research 
Annual Conference, March 21-24 2017, 
Addis Ababa, Ethiopia. 
41. Alemayehu M, Gelaw B, Abate E, et al. 
Active case finding for pulmonary 
tuberculosis and detection of drug 
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resistance among HIV-infected patients in 
Gondar, Ethiopia. 25th Annual Conference, 
Ethiopian Public Health Association; 
February 20-22, 2014; Addis Ababa, 
Ethiopia. Poster no. 32. 
42. Alemayehu M, Gelaw B, Abate E, et al. 
Active tuberculosis case finding and 
detection of drug resistance among HIV-
infected patients: A cross-sectional study in 
a TB endemic area, Gondar, Northwest 
Ethiopia. Int J Mycobacteriol 2014; 
3(2):132-8. doi: 
10.1016/j.ijmyco.2014.02.004. 
43. Alemayehu T, Ergete W, Abebe W. Frontal 
Lobe Tuberculoma: A Clinical and Imaging 
Challenge. Ethiop J Health Sci 2017; 
27(6):677-680. 
44. Alemu B, Nazir S, Tintagu T, Teklu A. 
Diagnostic efficacy of abattoir meat 
inspection for detecting bovine tuberculosis 
at Adama municipal abattoir, Ethiopia. 
Comparative Clinical Pathology 2016; 
25(4) pp. 885-893 
45. Alemu Chemeda. Use of urine as an adjunct 
specimen for the diagnosis of pulmonary 
tuberculosis in People Living with HIV in 
Addis Ababa. [MSc Thesis]: Addis Ababa 
University, 2015. 
46. Ali GY, Aseffa A, Yamogne LK, Aderaye 
G. Anti-tuberculosis drug induced 
hepatotoxicity in HIV positive and negative 
patients [PS-1357-20]. Int J Tuberc Lung 
Dis 2005; 9 (11 Suppl 1): S1 – S326. 
47. Ali I, Woldeamnuel Y, Mekasha A , Abebe 
M, Wassie L, Aseffa A. Comparison of 
tuberculosis skin test and 
QUANTIFERON-TB Gold in tube assay 
for diagnostic workup of childhood 
tuberculosis: a cross-sectional study 
conducted at Tikur Anbesa specialized 
hospital, Ethiopia.  Abstracts Presented on 
8th Annual Conference of TRAC, March 
21-24, 2013, Addis Ababa, Ethiopia. 
48. Ali I, Woldeamnuel Y, Mekasha A, Abebe 
A, Beyene D, Hailu E, Aseffa A. Molecular 
diversity of mycobacterium tuberculosis 
isolates from culture positive pediatric TB 
patients attending Tikure Anbessa 
specialized hospital, Ethiopia.  Abstracts 
Presented on 8th Annual Conference of 
TRAC, March 21-24, 2013, Addis Ababa, 
Ethiopia. 
49. Ali K, Klotz SA. The immune 
reconstitution inflammatory syndrome with 
tuberculosis: a common problem in 
Ethiopian HIV-infected patients beginning 
antiretroviral therapy. J Int Assoc 
Physicians AIDS Care (Chic) 2012; 
11(3):198-202. doi: 
10.1177/1545109711402212. 
50. Amare B, Meseret S, Yabutani T, Moges B, 
Kassu A. Hypercalcemia in patients with 
tuberculosis and HIV infections in 
Northwest Ethiopia. Asian Pacific J Trop 
Dis 2012; 2: 629–S634. 
51. Amare Y, Weldie M, Gebremichael G, 
Medhin G, Kassa D. Lipids as indirect 
biomarkers of pulmonary tuberculosis in 
patients with or without HIV infection in 
Addis Ababa, Ethiopia. 25th Annual 
Conference, Ethiopian Public Health 
Association; February 20-22, 2014; Addis 
Ababa, Ethiopia. Poster no. 21. 
52. Amare Y. Lipids and indirect biomarkers of 
pulmonary tuberculosis in patients with and 
without HIV infection. MSc Thesis: Addis 
Ababa University, 2014. 
53. Ambaw F, Mayston R, Hanlon C, Medhin 
G, Alem A. Course of untreated depression 
in people with tuberculosis in Ethiopia: a 
cohort study.  Abstracts Presented on 12th 
National TB Research Annual Conference, 
March 21-24 2017, Addis Ababa, Ethiopia. 
54. Ambaw F, Mayston R, Hanlon C, Medhin 
G, Alem A. Impact of untreated depression 
on TB treatment outcomes, disability and 
quality of life in Ethiopia: a cohort study 
[pp. S38]. Int J Tuberc Lung Dis 2017; 21 
(11 Suppl 2): S1 – S481. 
55. Ameni G, Aseffa A, Engers H, Young D, 
Hewinson G, Vordermeier M. Cattle 
husbandry in Ethiopia is a predominant 
factor affecting the pathology of bovine 
tuberculosis and gamma interferon 
responses to mycobacterial antigens. Clin 
Vaccine Immunol 2006; 13(9):1030-6. 
56. Ameni G, Aseffa A, Hewinson G, 
Vordermeier M. Comparison of different 
testing schemes to increase the detection 
Mycobacterium bovis infection in 
Ethiopian cattle. Trop Anim Health Prod 
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LIMITATION OF THE STUDY 
 
Although our literature search strategy was 
carefully developed to be comprehensive, it 
may not have captured all relevant literatures 
particularly the unpublished one, as the 
websites of some of the local universities were 
inaccessible or incomplete for resources and 
we could have missed to reach all potential 
source persons.  
 
CONCLUSION 
   
TB or TB/HIV and MDR-TB literatures in 
Ethiopia have substantially increased over years. 
Referred journal publications took the leading 
source and epidemiologic studies were the 
commonest one. Based on the evidence 
generated, it is time to focus on operational or 
implementation and health system researches to 
plummet the disease spreading, drug resistance 
and impact. Other than this, it is equally 
important to update the bibliography every 3 to 4 




We acknowledge the technical and financial 
support provided by KNCV Tuberculosis 
Foundation and USAID. We are also thankful of 
those institutions and individuals who had 
shared us their unpublished documents.  
 
 
 
 
 
